ArticleBMC cancer2013

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.

George Fountzilas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.